Literature DB >> 18619954

Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133.

Dylan Sweetman1, Katarzyna Goljanek, Tina Rathjen, Svetlana Oustanina, Thomas Braun, Tamas Dalmay, Andrea Münsterberg.   

Abstract

The expression of three microRNAs, miR-1, miR-206 and miR-133 is restricted to skeletal myoblasts and cardiac tissue during embryo development and muscle cell differentiation, which suggests a regulation by muscle regulatory factors (MRFs). Here we show that inhibition of C2C12 muscle cell differentiation by FGFs, which interferes with the activity of MRFs, suppressed the expression of miR-1, miR-206 and miR-133. To further investigate the role of myogenic regulators (MRFs), Myf5, MyoD, Myogenin and MRF4 in the regulation of muscle specific microRNAs we performed gain and loss-of-function experiments in vivo, in chicken and mouse embryos. We found that directed expression of MRFs in the neural tube of chicken embryos induced ectopic expression of miR-1 and miR-206. Conversely, the lack of Myf5 but not of MyoD resulted in a loss of miR-1 and miR-206 expression. Taken together our results demonstrate differential requirements of distinct MRFs for the induction of microRNA gene expression during skeletal myogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619954     DOI: 10.1016/j.ydbio.2008.06.019

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  119 in total

1.  miR-206 and -486 induce myoblast differentiation by downregulating Pax7.

Authors:  Bijan K Dey; Jeffrey Gagan; Anindya Dutta
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

2.  Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle.

Authors:  Søren Nielsen; Camilla Scheele; Christina Yfanti; Thorbjörn Akerström; Anders R Nielsen; Bente K Pedersen; Matthew J Laye; Matthew Laye
Journal:  J Physiol       Date:  2010-10-15       Impact factor: 5.182

3.  Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis.

Authors:  Vahab D Soleimani; Hang Yin; Arezu Jahani-Asl; Hong Ming; Christel E M Kockx; Wilfred F J van Ijcken; Frank Grosveld; Michael A Rudnicki
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

4.  MicroRNAs with a nucleolar location.

Authors:  Joan C Ritland Politz; Eric M Hogan; Thoru Pederson
Journal:  RNA       Date:  2009-07-23       Impact factor: 4.942

5.  MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation.

Authors:  Jeffrey Gagan; Bijan K Dey; Ryan Layer; Zhen Yan; Anindya Dutta
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

6.  Creating a flexible multiple microRNA expression vector by linking precursor microRNAs.

Authors:  Xiangning Qiu; Jeffrey M Friedman; Gangning Liang
Journal:  Biochem Biophys Res Commun       Date:  2011-06-24       Impact factor: 3.575

7.  Thyroid hormone may regulate mRNA abundance in liver by acting on microRNAs.

Authors:  Hongyan Dong; Martin Paquette; Andrew Williams; R Thomas Zoeller; Mike Wade; Carole Yauk
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

8.  MicroRNA transcriptome profiles during swine skeletal muscle development.

Authors:  Tara G McDaneld; Timothy P L Smith; Matthew E Doumit; Jeremy R Miles; Luiz L Coutinho; Tad S Sonstegard; Lakshmi K Matukumalli; Dan J Nonneman; Ralph T Wiedmann
Journal:  BMC Genomics       Date:  2009-02-10       Impact factor: 3.969

9.  Microrna-221 and microrna-222 modulate differentiation and maturation of skeletal muscle cells.

Authors:  Beatrice Cardinali; Loriana Castellani; Pasquale Fasanaro; Annalisa Basso; Stefano Alemà; Fabio Martelli; Germana Falcone
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

10.  Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states.

Authors:  Aaron L Sarver; Amy J French; Pedro M Borralho; Venugopal Thayanithy; Ann L Oberg; Kevin A T Silverstein; Bruce W Morlan; Shaun M Riska; Lisa A Boardman; Julie M Cunningham; Subbaya Subramanian; Liang Wang; Tom C Smyrk; Cecilia M P Rodrigues; Stephen N Thibodeau; Clifford J Steer
Journal:  BMC Cancer       Date:  2009-11-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.